. . . . . . . . . . . . . . . "p(HGNC:EGR1) -| tscript(p(HGNC:SP1))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Although the evidence implicating Egr-1 in IMPDH type II expression is circumstantial at present, the presence of a protected region (C) corresponding to the Egr-1 binding site in the IMPDH type II promoter and the requirement for increased IMPDH gene expression for T lymphocyte activation do suggest that this site could be of considerable functional importance. It has been observed, for example, that Egr-1 can act as a repressor of Sp1 activity at the coincident binding site in the adenosine deaminase gene promoter" . . "Selventa" . . . . "2014-07-03T14:33:47.081+02:00"^^ . . .